Saudi Arabia Human Primary Cell Culture Market Size & Outlook
Related Markets
Saudi Arabia human primary cell culture market highlights
- The Saudi Arabia human primary cell culture market generated a revenue of USD 18.8 million in 2024 and is expected to reach USD 35.6 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 11.3% from 2025 to 2030.
- In terms of segment, primary cells was the largest revenue generating product in 2024.
- Primary Cell Culture Media is the most lucrative product segment registering the fastest growth during the forecast period.
Human primary cell culture market data book summary
| Market revenue in 2024 | USD 18.8 million |
| Market revenue in 2030 | USD 35.6 million |
| Growth rate | 11.3% (CAGR from 2025 to 2030) |
| Largest segment | Primary cells |
| Fastest growing segment | Primary Cell Culture Media |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Primary Cells, Reagents and Supplements, Primary Cell Culture Media |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.5% of the global human primary cell culture market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia human primary cell culture market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 35.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Primary Cell Culture Market Scope
Human Primary Cell Culture Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AllCells | View profile | 51-100 | Alameda, California, United States, North America | https://www.allcells.com |
| Cell Biologics, Inc. | View profile | 1-10 | Chicago, Illinois, United States, North America | http://www.cellbiologics.net |
| Axol Bioscience | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | https://www.axolbio.com |
| ZenBio | View profile | 11-50 | Durham, North Carolina, United States, North America | http://www.zen-bio.com/ |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| Stemcell Holdings Inc Ordinary Shares | View profile | - | 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 | https://www.stemcell-holdings.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Saudi Arabia human primary cell culture market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human primary cell culture market will help companies and investors design strategic landscapes.
Primary cells was the largest segment with a revenue share of 36.17% in 2024. Horizon Databook has segmented the Saudi Arabia human primary cell culture market based on primary cells, reagents and supplements, primary cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
Companies like Saudi Biotech and the King Faisal Specialist Hospital & Research Centre are playing a pivotal role in adopting human primary cell cultures for research and development. Saudi Biotech, a leading pharmaceutical and biotech company.
primary cell cultures for vaccine development and other biologic therapies, contributing to the growth of the market.
Additionally, research centers such as the King Abdulaziz City for Science and Technology (KACST) and King Saud University are integrating primary cell culture technologies into their research programs to explore cancer therapies, genetic disorders, and stem cell research.
As Saudi Arabia continues to invest in biotechnology and healthcare research, the demand for human primary cell cultures is expected to rise, further accelerating the market’s development in the region.
Reasons to subscribe to Saudi Arabia human primary cell culture market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia human primary cell culture market databook
-
Our clientele includes a mix of human primary cell culture market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia human primary cell culture market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia human primary cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia Product - Human Primary Cell Culture Market size, 2024 - 2030 (US$M)
Saudi Arabia Human Primary Cell Culture Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
